MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute Report issue

Foundation Phase 4

Organization Overview

First Clinical Trial
2001
NCT00037102
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now